Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
Arnsten AF, Girgis RR, Gray DL, Mailman RB. Arnsten AF, et al. Among authors: mailman rb. Biol Psychiatry. 2017 Jan 1;81(1):67-77. doi: 10.1016/j.biopsych.2015.12.028. Epub 2016 Jan 18. Biol Psychiatry. 2017. PMID: 26946382 Free PMC article. Review.
Serotonergic basis of antipsychotic drug effects in schizophrenia.
Lieberman JA, Mailman RB, Duncan G, Sikich L, Chakos M, Nichols DE, Kraus JE. Lieberman JA, et al. Among authors: mailman rb. Biol Psychiatry. 1998 Dec 1;44(11):1099-117. doi: 10.1016/s0006-3223(98)00187-5. Biol Psychiatry. 1998. PMID: 9836014 Review.
Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder.
Rosell DR, Zaluda LC, McClure MM, Perez-Rodriguez MM, Strike KS, Barch DM, Harvey PD, Girgis RR, Hazlett EA, Mailman RB, Abi-Dargham A, Lieberman JA, Siever LJ. Rosell DR, et al. Among authors: mailman rb. Neuropsychopharmacology. 2015 Jan;40(2):446-53. doi: 10.1038/npp.2014.192. Epub 2014 Jul 30. Neuropsychopharmacology. 2015. PMID: 25074637 Free PMC article. Clinical Trial.
The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study.
Huang X, Lewis MM, Van Scoy LJ, De Jesus S, Eslinger PJ, Arnold AC, Miller AJ, Fernandez-Mendoza J, Snyder B, Harrington W, Kong L, Wang X, Sun D, Delnomdedieu M, Duvvuri S, Mahoney SE, Gray DL, Mailman RB. Huang X, et al. Among authors: mailman rb. J Parkinsons Dis. 2020;10(4):1515-1527. doi: 10.3233/JPD-202188. J Parkinsons Dis. 2020. PMID: 32986682 Free PMC article. Clinical Trial.
Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson's Disease.
Lewis MM, Van Scoy LJ, De Jesus S, Hakun JG, Eslinger PJ, Fernandez-Mendoza J, Kong L, Yang Y, Snyder BL, Loktionova N, Duvvuri S, Gray DL, Huang X, Mailman RB. Lewis MM, et al. Among authors: mailman rb. Biomolecules. 2023 May 12;13(5):829. doi: 10.3390/biom13050829. Biomolecules. 2023. PMID: 37238699 Free PMC article. Clinical Trial.
248 results